Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines

In vivo dendritic-cell targeting constitutes a promising strategy for anticancer vaccination. Here, we discuss the usage of multivalent DC-SIGN-targeting glycan platforms that allow for the efficient routing of antigens to the endo-lysosomal pathway as well as to a yet uncharacterized cross-presenta...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Vallejo, Juan J., Unger, Wendy W. J., Kalay, Hakan, van Kooyk, Yvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601176/
https://www.ncbi.nlm.nih.gov/pubmed/23525136
http://dx.doi.org/10.4161/onci.23040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601176/
https://www.ncbi.nlm.nih.gov/pubmed/23525136
http://dx.doi.org/10.4161/onci.23040

Ejemplares similares